Broadly neutralizing anti-HIV-1 antibodies that bind to an N-glycan epitope on the envelope
US11572403B2 · kind B2 · utility
0Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2020 |
| Grant date | Feb 7, 2023 |
| Priority date | — |
| Expiry date | Oct 6, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16111
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel anti-HIV antibodies that can be used in the treatment and detection of human immunodeficiency virus (HIV). These antibodies exhibit a high degree of sensitivity and can provide a broad range of specificity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.